Skip to main content
SpringerLink
Log in

Störungen durch Alkohol

  • Chapter
Psychiatrie und Psychotherapie

Zusammenfassung

Alkoholabhängigkeit und -missbrauch sind häufige psychische Störungen, bei Männern die häufigste überhaupt. Dies und die internistischen und neurologischen Folgeerkrankungen des Alkoholkonsums führen dazu, dass Störungen durch Alkohol ein erhebliches medizinisches (und soziales) Problem darstellen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kap. 49 und 50

  • Agarwal DP, Goedde HW (1990) Alcohol metabolism, alcohol intolerance and alcoholism. Biochemical and pharmacogenetic approaches. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Alldredge BK, Lowenstein PH, Simon RP (1989) Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 87: 645–648

    PubMed  CAS  Google Scholar 

  • Alterman AI, Hayashida M, O’Brien CP (1988) Treatment response and safety of ambulatory medical detoxification. J Stud Alcohol 49: 160–166

    PubMed  CAS  Google Scholar 

  • Amato L, Minozzi S, Davoli M et al. (2004) Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev: CD004147

    Google Scholar 

  • Arzneiverordnung in der Praxis: AkdÄ Arzneimittelkommission der deutschen Ärzteschaft (2001) Tabakabhängigkeit. Berlin

    Google Scholar 

  • Aulhorn E (1989) Die Tabak-Alkohol-Amblyopie. In: Schied HW, Heimann H, Mayer K (Hrsg) Der chronische Alkhoholismus. Grundlagen, Diagnostik, Therapie. Fischer, Stuttgart New York, S 163–174

    Google Scholar 

  • Ballenger JC, Post RM (1978) Kindling as a model for alcoholic withdrawal syndromes. Br J Psychiatry 133: 1–14

    PubMed  CAS  Google Scholar 

  • Batra A, Brömer A, Grüninger K et al. (1994) Verhaltenstherapeutische Raucherentwöhnung in Arztpraxen. Verhaltensmod Verhaltensmed 15: 364–376

    Google Scholar 

  • Batra A, Schütz CG, Linninger P (2006) Tabakabhängigkeit. In: Schmidt LG; Gastpar M, Falkai P, Gaebel W (Hrsg) Evidenzbasierte Suchtmedizin. Behandlung substanzbezogener Störungen. Deutscher Ärzteverlag, Köln, S 91–142

    Google Scholar 

  • Bayrische Akademie für Suchtfragen (1999) Leitfaden für Ärzte zur substitutionsgestützten Behandlung Opiatabhängiger. Bayrische Akademie für Suchtfragen, München

    Google Scholar 

  • Beck AT, Steer RA, McElroy MG (1982) Self-reported precedence of depression in alcoholism. Drug Alcohol Depend 10: 185–190

    PubMed  CAS  Google Scholar 

  • Benkert O, Hippius H (1996) Psychiatrische Pharmakotherapie, 6. Aufl. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Berglund M, Thelander S, Jonsson E (2003) Treating Alcohol and Drug Abuse. An Evidence Based Review. Wiley-VCH, Weinheim

    Google Scholar 

  • Berlin I, Said S, Spreux-Varoquaux O et al. (1995) A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 58: 444–452

    PubMed  CAS  Google Scholar 

  • Besson JAQ, Crawford JR, Parker DM, Smith FW (1989) Magnetic resonance imaging in Alzheimer’s disease, multi-infarkt-dementia, alcoholic dementia and Korsakoff’ psychosis. Acta Psychiatr Scand 80: 451–458

    PubMed  CAS  Google Scholar 

  • Bickel WK, Amass L, Crean JP, Badger GJ (1999) Buprenorphine dosing every 1,2,or 3 days in opioid-dependent patients. Psychopharmacology 146: 111–118

    PubMed  CAS  Google Scholar 

  • Bien Th, Miller WR, Tonigan JS (1993) Brief interventions for alcohol problems: a review. Addiction 88: 315–336

    PubMed  CAS  Google Scholar 

  • Blansjaar BA, Horjus MC, Nijhius HG (1987) Prevalence of the Korsakow syndrome in the Hague, The Netherlands. Acta Psychiatr Scand 75: 604–607

    PubMed  CAS  Google Scholar 

  • Bohn MJ, Hersh D (1994) Drugs for the treatment of psychiatric comorbidity in alcoholics: recent developments. In: Born GVR, Cuatrecasas P, Ganten D et al. (eds) The pharmacology of alcohol abuse. Handbook of experimental pharmacology, vol 114. Springer, Berlin Heidelberg New York Tokio, pp 416–441

    Google Scholar 

  • Bonnet U, Harries-Hedder K, Leweke FM et al. (2004) AWMF-Leitlinie: Cannabis-bezogene Störungen. Fortschr Neurol Psychiatr 72: 318–329

    PubMed  CAS  Google Scholar 

  • Bottlender M, Soyka M (2005) Outpatient alcoholism treatment. Predictors of outcome after three years. Alcohol Drug Depend 80: 83–89

    Google Scholar 

  • Bottlender M, Köhler J, Soyka M (2006) Effektivität psychosozialer Behandlungsmethoden zur medizinischen Rehabilitation alkoholabhängiger Patienten. Fortschr Neurol Psychiat 74: 19–31

    PubMed  CAS  Google Scholar 

  • Bouza C, Magro A, Munoz A et al. (2004) Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99: 811–828

    PubMed  Google Scholar 

  • Brady KT, Sonne SC, Anton R, Ballenger JC (1995) Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 56: 118–121

    PubMed  CAS  Google Scholar 

  • Brathen G, Ben-Menachem E, Brodtkorb E et al. (2005) EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force. Eur J Neurology 12: 575–581

    CAS  Google Scholar 

  • Bronisch T, Wittchen H-U (1992) Lifetime and 6-month prevalence of abuse and dependence of alcohol in the Munich Follow-Up Study. Eur Arch Psychiatry Clin Neurosci 241: 273–282

    PubMed  CAS  Google Scholar 

  • Bruno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology 22(Suppl 1): 49–59

    PubMed  Google Scholar 

  • Buchkremer G, Batra A (1995) Raucherentwähnung. In: Opitz K, Wirth W (Hrsg) Tabakrauchen und Raucherentwöhnung in Deutschland 1994. Fischer, Stuttgart Jena New York, S 117–125

    Google Scholar 

  • Buchkremer G, Bents H, Minneker E, Opitz K (1988) Langfristige Effekte einer Kombination von transdermaler Nikotinzufuhr mit Verhaltenstherapie zur Raucherentwöhnung. Nervenarzt 59: 488–490

    PubMed  CAS  Google Scholar 

  • Buchkremer G, Minneker E, Block M (1991) Smoking cessation treatment, combining transdermal nicotine substitution with behavioral therapy. Pharmacopsychiatry 24: 96–102

    PubMed  CAS  Google Scholar 

  • Burkhardt E (1989) Intoxikation mit Carbamazepin bei bestehender Alkoholabhängigkeit in suizidaler Absicht — Eine Kasuistik. In: Müller-Oerlinghausen B, Haas S, Stoll K-D (Hrsg) Carbamazepin in der Psychiatrie. Thieme, Stuttgart, S 79–80

    Google Scholar 

  • Bühringer G, Augustin R, Bergmann E et al. (2002) Alcohol Consumption and Alcohol-Related Problems in Germany. Hogrefe & Huber Publishers, Seattle Toronto Bern Göttingen

    Google Scholar 

  • Caroll KM, Rounsaville BJ, Gawin FH (1994) A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse 17: 229–247

    Google Scholar 

  • Charney DS, Heniger GR, Jatlow PL (1985) Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42: 233–243

    PubMed  CAS  Google Scholar 

  • Ciraulo DA, Barnhill J, Boxenbaum H (1985) Pharmakokinetic interaction of disulfiram and antidepressants. Am J Psychiatry 142: 1373–1374

    PubMed  CAS  Google Scholar 

  • Ciraulo DA, Barnhill JG, Jaffe JH et al. (1990) Intravenous pharmakokinetics of 2-hydroxyimipramine in alcoholics and normal controls. J Stud Alcohol 51: 366–372

    PubMed  CAS  Google Scholar 

  • Clasing D (1992) Doping — verbotene Arzneimittel im Sport. Fischer, Stuttgart

    Google Scholar 

  • Conde-Martel A, Gonzalez-Reimers E, Santolaria-Fernandez F et al. (1992) Pathogenesis of alcoholic myopathy: roles of ethanol and malnutrition. Drug Alcohol Depend 30: 101–110

    PubMed  CAS  Google Scholar 

  • Cornelius JR, Fisher BW, Salloum IM et al. (1992) Fluoxetine trial in depressed alcoholics. Alcohol Clin Exp Res 16: 362

    Google Scholar 

  • Cornelius J, Salloum IM, Cornelius MD et al. (1993) Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol Bull 29: 195–199

    PubMed  CAS  Google Scholar 

  • Cotton J (1979) The familial incidence of alcoholism. A review. J Stud Alcohol 40: 89–116

    PubMed  CAS  Google Scholar 

  • Daly JW (1993) Mechanisms of action of caffeine. In: Garattini S (ed) Caffeine, coffee, and health. Raven, New York, pp 97–150

    Google Scholar 

  • Davidson KM (1995) Diagnosis of depression in alcohol dependence. Br J Psychiatry 166: 199–204

    PubMed  CAS  Google Scholar 

  • Di Chiara G, North RA (1992) Neurobiology of Opiate Abuse. TIPS 13: 187

    Google Scholar 

  • Dittert S, Naber D, Soyka M (1999) Methadonsubstitution und Fahrtauglichkeit — Ergebnisse einer experimentellen Studie. Nervenarzt 70: 457–462

    PubMed  CAS  Google Scholar 

  • Dole VP, Nyswander ME (1965) A medical treatment for diacety-morphine (heroine-) addiction. JAMA 193: 646–650

    PubMed  CAS  Google Scholar 

  • Dorus W, Ostrow DG, Anton R et al. (1989) Lithium therapy of depressed and nondepressed alcoholics. JAMA 262: 1646–1652

    PubMed  CAS  Google Scholar 

  • Egberts EH (1993) Hepatische Enzephalopathie. In: Schüttler R (Hrsg) Organische Psychosyndrome. Tropon-Symposion Bd VIII. Springer, Berlin Heidelberg New York Tokio, S 183–194

    Google Scholar 

  • Einhorn LC, Johansen PA, White FJ (1988) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegemental area. J Neurosci 8: 100–112

    PubMed  CAS  Google Scholar 

  • Emrick CD, Tonigan JS, Montgomery H, Little L (1993) Alcoholics Anonymous: what is currently known? In: McGrady BS, Miller WR (eds) Research on Alcoholics Anonymous. Alcohol Research Documentation, New Brunswick/Canada, pp 41–76

    Google Scholar 

  • Ericksen L, Bjornstadt S, Gotestam G (1986) Social skills training in groups for alcoholics: one-year treatment outcome for groups and individuals. Addict Behav 11: 309–329

    Google Scholar 

  • Fagerstrom KO, Heatherton TF, Kozlowski LT (1991) Nicotine Addiction and its Assessment. Ear, Nose Throat J 69: 763–768

    Google Scholar 

  • Fawcett J, Clark DC, Aagesen CA et al. (1987) A double-blind, placebocontrolled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiatry 44: 248–256

    PubMed  CAS  Google Scholar 

  • Feuerlein W (1989) Alkoholismus — Mißbrauch und Abhängigkeit, 4. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Feuerlein W, Küfner H (1989) A prospective multicenter study on inpatient treatment for alcoholics: 18-and 48-months follow-up (Munich Evaluation for Alcoholism Treatment, MEAT). Eur Arch Psychiatry Neurol Sci 239: 144–157

    PubMed  CAS  Google Scholar 

  • Feuerlein W, Küfner H, Soyka M: Alkohol (1998) Alkohol — Mißbrauch und Abhängigkeit. 5. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Fichter MM (1997) Epidemiologie von Alkoholmißbrauch und-abhängigkeit. In: Soyka M, Möller HJ (Hrsg) Alkoholismus als psychische Störung. Springer, Berlin Heidelberg New York Tokio, S 1–11

    Google Scholar 

  • Fichter MM, Frick U (1992) Therapie und Verlauf von Alkoholabhängigkeit. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Fichter MM, Narrow WE, Roper MT et al. (1996) Prevalence of mental illness in Germany and the United States. Comparison of the Upper Bavarian Study and the Epimemiological Catchment Area Program. J Nerv Ment Dis 184: 598–606

    PubMed  CAS  Google Scholar 

  • Fischer G, Johnson RE, Eder H et al. (2000) Treatment of opioiddependent pregnant women with buprenorphine. Addiction 95: 239–244

    PubMed  CAS  Google Scholar 

  • Fleischhacker WW, Günther V, Barnas Ch et al. (1986) Piracetam in alcoholic organic mental disorders: a placebo controlled study comparing two dosages. Int J Psychopharmacol 1: 210–215

    CAS  Google Scholar 

  • Fowler JS et al. (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379: 733–736

    PubMed  CAS  Google Scholar 

  • Fuente J-R de la, Morse RM, Niven RG, Ilstrup DM (1989) A controlled study of lithium carbonate in the treatment of alcoholism. Mayo Clin Proc 64: 177–180

    PubMed  Google Scholar 

  • Fuller RK, Branchey L, Brightwell DR et al. (1986) Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA 256: 1449–1455

    PubMed  CAS  Google Scholar 

  • Gable RS (1993) Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically. Am J Drug Alcohol Abuse 19: 263–281

    PubMed  CAS  Google Scholar 

  • Gallimberti L, Canton G, Gentile N et al. (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2: 787–789

    PubMed  CAS  Google Scholar 

  • Gardner EL, Lowinson JH (1991) Marijuana’s interaction with brain reward systems: update 1991. Pharmacol Biochem Behav 40: 571

    PubMed  CAS  Google Scholar 

  • Garner M et al. (1985) The validity of the distinction between bulimia with and without anorexia nervosa. Am J Psychiatry 142: 581

    PubMed  CAS  Google Scholar 

  • Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnoses in cocaine abusers. Arch Gen Psychiatry 43: 107–113

    PubMed  CAS  Google Scholar 

  • Gawin FH, Kleber HD, Byck R et al. (1989 b) Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 46: 117–121

    PubMed  CAS  Google Scholar 

  • Geller B, Cooper TB, Watts HE et al. (1992) Early findings from a pharmacokinetically designed, double-blind, placebo-controlled study of lithium for adolescents with comorbid bipolar and substance dependence disorders. Prog Neuropsychopharmacol Biol Psychiatry 16: 281–299

    PubMed  CAS  Google Scholar 

  • Gessner PK (1992) Substance abuse treatment. In: Smith CM, Reynard AM (eds) Textbook of pharmacology. Saunders, Philadelphia, p 1160

    Google Scholar 

  • Geyer D, Batra A, Beutel M et al. (2006) AWMF-Leitlinie: Postakutbehandlung alkoholbezogener Stärungen. Sucht 52: 8–34

    Google Scholar 

  • Glaeske G (1996) Psychotrope und andere Arzneimittel mit Mißbrauchs-und Abhängigkeitspotential. DHS (Hrsg) Jahrbuch Sucht 97. Neuland, Geesthacht, S 87–103

    Google Scholar 

  • Gold LH, Geyer MA, Koob GF (1989) Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr 94: 101–126

    PubMed  CAS  Google Scholar 

  • Gold MS (1992) Cocaine (and Crack): clinical aspects. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds) Substance abuse: a comprehensive textbook, 2nd edn. Williams & Wilkins, Baltimore, p 205

    Google Scholar 

  • Gold MS (1997) Cocaine (and Crack): clinical aspects. In: Lowison JH, Ruiz P, Milman RB, Langrod JG (eds) Substance abuse: a comprehensive textbook, 3. edn. Williams and Wilkins, Baltimore, pp 181–199

    Google Scholar 

  • Gossop M, Marsden J (1996) Assessment and treatment of opiate problems. Baillieres Clin Psychiatry 2: 445–459

    Google Scholar 

  • Gottesleben A, Willemsen D, Wolf C (1995) Retardiertes Carbamazepin in der Therapie des alkoholischen Prädelirs. Akt Neurol 22: 60–65

    Google Scholar 

  • Gowing L, Ali R, White J (2006) Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev: CD002025

    Google Scholar 

  • Graham JR, Woodhouse D, Read FH (1971) Massive thiamine dosage in an alcoholic with cerebellar cortical degeneration. Lancet 2: 107

    PubMed  CAS  Google Scholar 

  • Grant BF, Dawson DA, Stinson FS et al. (2004) The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002. Drug Alcohol Depend 74: 223–234

    PubMed  Google Scholar 

  • Gross MM, Rosenblatt SM, Malenowski B et al. (1971) A factor analytic study of the clinical phenomena in the acute alcohol withdrawal syndromes. Press of Addiction Res. Foundation, Toronto

    Google Scholar 

  • Grüngreiff K (1996) Zinkmangel und hepatische Enzephalopathie. Med Welt 47: 23–27

    Google Scholar 

  • Harper C (1979) Wernicke’s encephalopathy: a more common disease than realised. A neuropathological study of 51 cases. J Neurol Neurosurg Psychiatry 42: 226–231

    PubMed  CAS  Google Scholar 

  • Harper C, Gold J, Rodriguez N, Perdices N (1989) The prevalence of the Wernicke-Korsakoff Syndrome in Sydney, Australia: a prospective necropsy study. J Neurol Neurosurg Psychiatry 52: 282–285

    PubMed  CAS  Google Scholar 

  • Haupt HA (1993) Anabolic steroids and growth hormone. Am J Sports Med 21: 468–474

    PubMed  CAS  Google Scholar 

  • Haustein KO (2000) Pharmacotherapy of nicotine dependence. Int J Clin Pharmacol Ther 38: 273–290

    PubMed  CAS  Google Scholar 

  • Havemann-Reinecke U, Küfner H, Schneider U et al. (2004) AWMF-Leitlinie: Postakutbehandlung bei Störungen durch Opioide. Sucht 50: 226–257

    Google Scholar 

  • Heigl-Evers A, Schultze-Dierbach E, Standke G (1991) Grundstörungen der Abhängigkeit und Sucht aus tiefenpsychologischer Sicht. In: Wanke K, Bühringer G (Hrsg) Grundstörungen der Sucht. Springer, Berlin Heidelberg New York Tokio, S 37–54

    Google Scholar 

  • Herbst (1995) Umfang des Mißbrauchsverhaltens in der Bevölkerung. Politische Studien, Heft 344

    Google Scholar 

  • Hesselbrock MN, Hesselbrock VM, Tennen H et al. (1983) Methodological consideration in the assessment of depession in alcoholics. J Consult Clin Psychol 51: 399–405

    PubMed  CAS  Google Scholar 

  • Hillbom M, Pieninkeroinen I, Leone M (2003) Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 17: 1013–1030

    PubMed  CAS  Google Scholar 

  • Holly A, Türk D, Nelson CB et al. (1997) Prävalenz von Alkoholkosum, Alkoholmissbrauch und-abhängigkeit bei Jugendlichen und jungen Erwachsenen. Z Klin Psychol 26: 171–178

    Google Scholar 

  • Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29: 307–313

    PubMed  CAS  Google Scholar 

  • Howlett AC, Champion-Dorow TM, McMahon LL, Westlake TM (1991) The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells. Pharmacol Biochem Behav 40: 565–569

    PubMed  CAS  Google Scholar 

  • Hrubec Z, Omenn GS (1981) Evidence of genetic disposition to alcoholic cirrhosis and psychosis: Twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 5: 207–215

    PubMed  CAS  Google Scholar 

  • Hser YI, Anglin DA, Powers K (1993) A 24-year Follow-up of California Narcotic Addicts. Arch Gen Psychiatry 50: 577–584

    PubMed  CAS  Google Scholar 

  • Hubbard RL, Mardsen ME, Rachal JV et al. (1989) Drug abuse treatment: a national study of effectiveness. University of North Carolina Press, Chapel Hill/NC

    Google Scholar 

  • Iwersen-Bergmann S, Schmolt A, Pöschel K, Schulz M (1999) Vergiftungs-und Todesfälle durch Substitutionsmittel im Umfeld von substituierten Drogenabhängigen. Rechtsmedizin 9: 90–93

    Google Scholar 

  • Jaffe JW (1990) Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman’s and Gilman’s — The pharmacological basis of therapeutics, 8th edn. Pergamon, New York, pp 549–553

    Google Scholar 

  • Jarvik ME, Schneider NG (1992) Nicotine. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds) Substance abuse: a comprehensive textbook, 2nd edn. Williams & Wilkins, Baltimore, pp 339–340

    Google Scholar 

  • Jernigan TL, Butters N, Ditraglia G et al. (1991) Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Resp 15: 418–427

    CAS  Google Scholar 

  • Johnson BA, Ait-Daoud N (2000) Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology 149: 327–344

    PubMed  CAS  Google Scholar 

  • Johnson BA, Ait-Daoud N, Bowden CL et al. (2003). Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361: 1677–1685

    PubMed  CAS  Google Scholar 

  • Jones SL, Kanfer R, Lanyon RI (1982) Skills training with alcoholics: a clinical extension. Addict Behav 7: 285–290

    PubMed  CAS  Google Scholar 

  • Julien RM (1997) Drogen und Psychopharmaka. Spektrum, Heidelberg Berlin Oxford

    Google Scholar 

  • Junge B (1995) Alkohol. In: Deutsche Hauptstelle gegen Suchtgefahren (Hrsg) Jahrbuch Sucht 1996. Neuland, Geesthacht, S 9–22

    Google Scholar 

  • Kashkin KB (1992) Anabolic steroids. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds) Substance abuse: a comprehensive textbook, 2nd edn. Williams & Willkins, Baltimore, pp 380–395

    Google Scholar 

  • Kessler RC, Crum RM, Warner LA et al. (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54: 313–321

    PubMed  CAS  Google Scholar 

  • Keup W (1993) Mißbrauchsmuster bei Abhängigkeit von Alkohol, Medikamenten und Drogen. Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976–1990. Lambertus, Freiburg i. Br.

    Google Scholar 

  • Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254: 576–578

    Google Scholar 

  • King GR, Ellinwood Jr EH (1992) Amphetamines and other stimulants. In: Lowinson JH, Ruiz P, Millman RB (eds) Substance abuse: a comprehensive textbook, 2nd edn. Williams & Wilkins, Baltimore, pp 247–266

    Google Scholar 

  • Kline NS, Wren JC, Cooper TB et al. (1974) Evaluation of lithium therapy in chronic and periodic alcoholism. Am J Med Sci 268: 15–22

    PubMed  CAS  Google Scholar 

  • Klotz U, Laux G (1996) Tranquillantien. Therapeutischer Einsatz und Pharmakologie. 2. Aufl. Wiss Verlagsges, Stuttgart

    Google Scholar 

  • Kosten TR (2002) Pathophysiology and treatment of cocaine dependence. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology, The fifth generation of progress. Philadelphia: Lippincott, Williams & Wilkins, pp 1461–1473

    Google Scholar 

  • Krämer G, Rothacker G, Theison M (1989) Intoxikation bei ambulanter Therapie eines Alkoholentzugssyndroms mit Carbamazepin in Retardform. In: Müller-Oerlinghausen B, Haas S, Stoll KD (Hrsg) Carbamazepin in der Psychiatrie. Thieme, Stuttgart, S 76–78

    Google Scholar 

  • Kranzler HR, Del Boca FK, Korner P, Brown J (1990) Fluvoxamine is poorly tolerated by alcoholics. In: Naranjo CA, Sellers EM (eds) Novel pharmacological interventions for alcoholism. Springer, Berlin Heidelberg New York Tokio, pp 304–308

    Google Scholar 

  • Kranzler HR, Burleson JA, Korner P et al. (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152: 391–397

    PubMed  CAS  Google Scholar 

  • Kraus L, Augustin R (2001) Repräsentative Erhebung zum Gebrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland 2000. Sucht 47, Sonderheft 1

    Google Scholar 

  • Kraus L, Augustin R, Röder J (2006) Trends im Konsum von Alkohol, Tabak und illegalen Drogen. Ergebnisse des epidemiologischen Sucht-Survey von 1980 bis 2003. In: DHS (Hrsg) Jahrbuch Sucht. Neuland Verlag, Geesthacht, S 141–153

    Google Scholar 

  • Kretz FJ, Löscher W, Peisdersky B et al. (1990) Flumazenil (Anexate): Pharmakodynamik, Pharmakokinetik, Indikationen und Kontraindikationen. Med Klin 85: 156–160

    CAS  Google Scholar 

  • Krystal JH, Webb E, Cooney N et al. (1994) Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. Arch Gen Psychiatry 51: 898–911

    PubMed  CAS  Google Scholar 

  • Kurella B, Heitmann A, Dormann S, Meister K (1990 a) Schlafpolygraphische Untersuchungen und subjektive Schlafeinschätzungen bei abstinenten Alkoholikern. Z Klin Med 45: 1519–1522

    Google Scholar 

  • Kurella B, Heitmann A, Dormann S, Meister K (1990 b) Besonderheiten des Schlafes bei abstinenten Alkoholikern. Vergleich alkohol-und altersbedingter Tiefschlafreduktion. Z EEG EMG 21: 157–160

    CAS  Google Scholar 

  • Längle G, Schäfer D, Mann K (1994) Der Langzeitverlauf bei Alkoholikern — 16 Jahre nach der Therapie. Vortrag auf der 10. Wissenschaftlichen Tagung der Dt. Gesellschaft für Suchtforschung und Suchttherapie. Tübingen 06.–09.04.1994

    Google Scholar 

  • Langen D (1991) Autogenes Training für Jeden. Gräfe & Unzer, München

    Google Scholar 

  • Langlais PJ, Mair RG (1990) Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 10: 1664–1674

    PubMed  CAS  Google Scholar 

  • Laux G (1995) Aktueller Stand der Therapie mit Benzodiazepinen. Eine Übersicht. Nervenarzt 66: 311–322

    PubMed  CAS  Google Scholar 

  • Leone M, Tonini C, Bogliun G et al. (2002) Chronic alcohol use and first symptomatic epileptic seizures. J Neurol Neurosurg Psychiatry 73: 495–499

    PubMed  CAS  Google Scholar 

  • Levin ED (1992) Nicotine systems and cognitive function. Psychopharmacology 108: 417–431

    PubMed  CAS  Google Scholar 

  • Leweke FM, Gerth CW, Klosterkotter J (2004) Cannabis-associated psychosis: current status of research. CNS Drugs 18: 895–910

    PubMed  Google Scholar 

  • Ling W, Rawson RA (1996) Opiatsubstitutionsprogramme in den USA: Von Methadon zu LAAM und Buprenorphin. In: Bundesamt für Gesundheitswesen (Hrsg) Ärztliche Verschreibung von Betäubungsmitteln. Huber, Bern Göttingen Toronto Seattle, S 268–282

    Google Scholar 

  • Lishman WA (1990) Alcohol and the brain. Br J Psychiatry 156: 635–644

    PubMed  CAS  Google Scholar 

  • Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90: 1179–1188

    PubMed  CAS  Google Scholar 

  • Lorenz W, Ollenschläger G (2000) Das Leitlinien-Manual der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) und der ärztlichen Zentralstelle Qualitätssicherung (äZQ). Z ärztl Fortbild Qualitätssich ZaeFQ

    Google Scholar 

  • Lynn AB, Herkenham M (1994) Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 268: 1612–1623

    PubMed  CAS  Google Scholar 

  • Maier W (1997) Mechanismen der familiären Übertragung von Alkoholabhängigkeit und Alkoholabusus. In: Watzl H, Rockstroh B (Hrsg) Abhängigkeit und Mißbrauch. Hogrefe, Göttingen, S 91–110

    Google Scholar 

  • Majumdar SK (1990) Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 27: 201–207

    Google Scholar 

  • Malcolm R, Anton RF, Randall CL et al. (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16: 1007–1013

    PubMed  CAS  Google Scholar 

  • Maldonado R, Valverde O, Bereberrendero V (2006) Involvement of the endocannabinoidsystem in drug addiction. Trends Neuro Sci 29: 225–232

    CAS  Google Scholar 

  • Malec E, Malec T, Gagné MA, Dongier M (1996) Buspirone in the treatment of alcohol dependence: A placebo-controlled trial. Alcohol Clin Exp Res 20: 307–312

    PubMed  CAS  Google Scholar 

  • Mann K, Lehert P, Morgan MY (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 28: 33

    Google Scholar 

  • Marlatt GA, Gordon JR (1985) Relapse prevention: maintenance strategies in treatment of addictive behaviors. Guilford, New York

    Google Scholar 

  • Martin PR, Adinoff B, Eckardt MJ et al. (1990) Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings [see comments]. Arch Gen Psychiatry 46: 617–621

    Google Scholar 

  • Martin PR, Rio D, Adinoff B et al. (1992) Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism. J Neuropsychiatr Clin Neurosci 4: 159–167

    CAS  Google Scholar 

  • Martin PR, Adinoff B, Lane E et al. (1995) Fluvoxamine treatment of alcoholic amnestic disorder. Eur Neuropsychopharmacol 5: 27–33

    PubMed  CAS  Google Scholar 

  • Mason BJ, Kocsis JH (1991) Desipramine treatment of alcoholism. Psychpharmacol Bull 27: 155–161

    CAS  Google Scholar 

  • Mason BJ, Koscis JH, Ritvo EC, Cutler RB (1996) A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence of absence of major depression. JAMA 275: 761–767

    PubMed  CAS  Google Scholar 

  • Matsuda LA, LoLait SJ, Brownstein MJ et al. (1990) Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564

    PubMed  CAS  Google Scholar 

  • Mattick RP, Kimber J, Breen C, Davoli M (2004) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev: CD 002207

    Google Scholar 

  • Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A Meta-analysis and evidence-based practice guideline. JAMA 278: 144–151

    PubMed  CAS  Google Scholar 

  • McCrady BS, Noel NE, Abrams DB et al. (1986) Comparative effectiveness of three types of spouse involvement in outpatient behavioral alcoholism reatment. J Stud Alcohol 47: 459–467

    PubMed  CAS  Google Scholar 

  • McEntee WJ, Mair RG (1980) Memory enhancement in Korsakow’s psychosis by clonidine: Further evidence for a noradrenergic deficit. Ann Neurol 7: 466–470

    PubMed  CAS  Google Scholar 

  • McGrath PJ, Nunes EV, Stewart JW et al. (1996) Imipramine treatment of alcoholics with primary depression. A placebo-controlled clinical trial. Arch Gen Psychiatry 53: 232–240

    PubMed  CAS  Google Scholar 

  • Merry J, Reynolds CM, Bailey J, Coppen A (1976) Prophylactic treatment of alcoholism by lithium carbonate: A controlled study. Lancet ii: 481–482

    Google Scholar 

  • Miller NS, Hoffmann NG (1995) Addictions treatment outcomes. Alcohol Treatment Q 12: 41–55

    Google Scholar 

  • Miller WR, Rollnick S (1991) Motivational Interviewing. Guilford, New York

    Google Scholar 

  • Miller WR, Rollnick S (1999) Motivierende Gesprächsführung — ein Konzept zur Beratung von Menschen mit Suchtproblemen. Freiburg: Lambertus

    Google Scholar 

  • Miller WR, Brown JM, Simpson TL et al. (1995) What works? A methodological analysis of the alcohol analysis of the alcohol treatment outcome literature. In: Hester RK, Miller WR (eds) Handbook of alcoholism treatment approaches: effective alternatives. Allyn & Bacon, Boston/MA, pp 12–44

    Google Scholar 

  • Moak DH, Anton RF (1995) An open-label trial of sertraline in depressed alcoholic outpatients. Alcohol Clin Exp Res 19(Suppl): 17A (Abstract 82)

    Google Scholar 

  • Mooney HB (1965) Pathologic jealousy and psychotherapy. Br J Psychiatrie 111: 1023–1042

    CAS  Google Scholar 

  • Morgan J, McSharry K, Sireling L (1990) Comparison of a system of staff prompting with a programmable electronic diary in a patient with korsakoff’s syndrome. Int J Soc Psychiatry 36: 225–229

    PubMed  CAS  Google Scholar 

  • Muller TI, Rudden S, Stout R et al. (1995) Carbamazepine for alcohol dependence — a pilot study. Alcohol Clin Exp Res 19(Suppl):17 A (Abstract-No. 84 A)

    Google Scholar 

  • Mukherjee AB, Ghazanfari A, Svoronos S et al. (1987) Transketolase abnormality in culured fibroblasts from familial chronic alcoholic men and their male offspring. J Clin Invest 79: 1039

    PubMed  CAS  Google Scholar 

  • Mullen KD, Szauter KM, Kaminsky-Russ K (1990) »Endogeneous« benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336: 81

    PubMed  CAS  Google Scholar 

  • Mundle G, Banger M, Mugele B et al. (2003) AWMF-Behandlungsleitlinie: Akutbehandlung alkoholbezogener Störungen. Sucht 49: 147–167

    Google Scholar 

  • Naber M, Franz W, Overbeck W (1991) Besonderheiten des Alkoholentzugsdelirs beim chirurgischen Patienten und Hinweise zur Behandlung. Chirurg 62: 133–137

    PubMed  CAS  Google Scholar 

  • Naranjo CA, Sellers EM, Roach CA et al. (1984) Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers. Clin Pharmacol Ther 35: 374–381

    PubMed  CAS  Google Scholar 

  • Naranjo CA, Sellers EM, Sullivan JT et al. (1987) The serotonine uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41: 266–274

    PubMed  CAS  Google Scholar 

  • Naranjo CA, Kadlec KE, Sanhuezza P, Sellers EM (1990) Fluoxetine differentially alters alcohol intake and other consumary behaviors in problem drinkers. Clin Pharmacol Ther 47: 490–498

    PubMed  CAS  Google Scholar 

  • Naranjo CA, Poulos CX, Bremner KE, Lanctot KL (1992) Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers. Clin Pharmacol Ther 51: 729–739

    PubMed  CAS  Google Scholar 

  • Naylor CD, O’Rourke K, Detsky AS, Baker JP (1988) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 97: 1033–1042

    Google Scholar 

  • Nixon PF (1984) Is there a genetic component to the pathogenesis of the Wernicke-Korsakoff syndrome? Alcohol Alcohol 19: 219–221

    PubMed  CAS  Google Scholar 

  • Nunes EV, McGrath PJ, Quitkin FM et al. (1993) Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 150: 963–965

    PubMed  CAS  Google Scholar 

  • Olney JW (1984) Excitotosins: An overview. In: Fuxe K, Roberts PJ, Scharcz R (eds) Excitotoxins. Macmillan, London, pp 82–96

    Google Scholar 

  • O’Malley SS, Jaffe AJ, Chang G et al. (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49: 881–887

    PubMed  Google Scholar 

  • Parsons O, Nixon S (1996) Die neuropsychologische Diagnostik des Alkoholismus: Gegenwärtiger Stand und künftige Perspektiven. In: Mann K, Buchkremer G (Hrsg) Sucht — Grundlagen, Diagnostik, Therapie. Fischer, Stuttgart, S 121–134

    Google Scholar 

  • Peachey JE, Annis HM, Bornstein ER et al. (1989) Calcium carbamide in alcoholism treatment. Part 1: a placebo-controlled, double-blind clinical trial of short-term efficacy. Br J Addict 84: 877–887

    PubMed  CAS  Google Scholar 

  • Penning R, Betz P, Meyer L v, Soyka M (1993) Drogentodesfälle mit Methadonbeteiligung. Nervenheilkunde 4: 183–186

    Google Scholar 

  • Petry J (1993) Alkoholismustherapie. PVU/Beltz, Weinheim

    Google Scholar 

  • Pfeiffer J (1985) Zur Frage atrophisierender Vorgänge im Gehirn chronischer Alkoholiker. Nervenarzt 56: 649–657

    Google Scholar 

  • Pfeiffer J (1989) neuropathologische Aspekte des chronischen Alkoholismus. In: Schied HW, Heimann H, Mayer K (Hrsg) Der chronische Alkoholismus. Fischer, Stuttgart New York, S 103–120

    Google Scholar 

  • Pisani VC, Fawcett J, Clark DC (1993) The relative contributions of medication adherence and AA meeting attendance to abstinent outcome for chronic alcoholics. J Stud Alcohol 54: 115–119

    PubMed  CAS  Google Scholar 

  • Plauth M, Egberts EH (1993) Was ist gesichert in der Therapie der hepatischen Enzephalopathie. Internist 34: 35–42

    PubMed  CAS  Google Scholar 

  • Poser W, Poser S (1996) Medikamente — Mißbrauch und Abhängigkeit. Thieme, Stuttgart

    Google Scholar 

  • Poser W, Böning J, Holzbach R, Schmidt LG (2006) Medikamentenabhängigkeit (Sedativa, Hypnotika, Analgetika, Psychostimulantien). In: Schmidt LG, Gastpar N, Falkai P, Gaebel W (Hrsg) Evidenzbasierte Suchtmedizin. Dt Ärzte Verl, Köln, S 271–307

    Google Scholar 

  • Preuss UW, Soyka M (1997) Das Wernicke-Korsakow-Syndrom; Klinik, Pathophysiologie und therapeutische Ansätze. Fortschr Neurol Psychiatr 65: 413–420

    PubMed  CAS  Google Scholar 

  • Preuss U, Bahlmann M, Koller G, Soyka M (2000) Die Behandlung der Kokain-Abhängigkeit: Intoxikation, Entzug und Rückfallprophylaxe. Fortschr Neurol Psychiat 68: 224–238

    PubMed  CAS  Google Scholar 

  • Prochaska JO, DiClemente CC (1986) Towards a comprehensive model of change. In: Miller WE, Heather N (eds) Treating addictive behaviors. Process of change. New York, London: Plenum Press, pp 265–273

    Google Scholar 

  • Pulvirenti L, Swerdlow NR, Koob GF (1991) Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin, or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav 40: 841–845

    PubMed  CAS  Google Scholar 

  • Regier DA, Boyd JH, Burke JD et al. (1988) One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 45: 977–986

    PubMed  CAS  Google Scholar 

  • Regier DA, Farmer ME, Rae DS et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511–2518

    PubMed  CAS  Google Scholar 

  • Reymann G, Gastpar M, Tretter F et al. (2003) AWMF-Leitlinie: Akutbehandlung opioidbezogener Störungen (s. AWMF Internet)

    Google Scholar 

  • Robins LN, Helzer JE, Przybeck TR, Regier DA (1988) Alcohol disorders in the community: a report from the Epidemiologic Catchment Area. In: Rose RM, Barrett JE (eds) Alcoholism. Origins and outcome. Raven, New York, pp 15–29

    Google Scholar 

  • Rohner HG, Bergers W, Wienbeck M (1982) Clomethiazole tablets induce ulcers in the esophagus. Z Gastroenterol 20: 469–473

    PubMed  CAS  Google Scholar 

  • Rohsenow DJ, Monti PM, Martin RA et al. (2000) Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol 68: 515–520

    PubMed  CAS  Google Scholar 

  • Rounsaville BJ, Anton SF, Carroll K et al. (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48: 43–51

    PubMed  CAS  Google Scholar 

  • Rubenstein AE, Wineapel SF (1977) Acute hypokalemic myopathy in alcoholism. Arch Neurol 34: 553–555

    PubMed  CAS  Google Scholar 

  • Salvato FR, Mason BJ, Williams LD (1995) Sertraline treatment of depression concomittant with nalmefene treatment of alcoholism: A case study. Alcohol Clin Exp Res 19(Suppl):17A (Abstract No 79)

    Google Scholar 

  • Sandoz M, Vandel S, Vandel B et al. (1983) Biotransformation of amitryptiline in alcoholic depressive patients. Eur J Clin Pharmacol 24: 615–621

    PubMed  CAS  Google Scholar 

  • Sapolsky RM, Pulsinelli WA (1985) Glucocorticoids potentiate ischaemic injury to neurons: therapeutic implications. Science 229: 1397–1400

    PubMed  CAS  Google Scholar 

  • Saß H, Soyka M, Mann K, Zieglgänsberger W (1996) Relapse prevention by acamprosate: results from a placebo controlled study on alcohol dependence. Arch Gen Psychiatry 53: 673–680

    PubMed  Google Scholar 

  • Satel SL, Kosten TR, Schuckit MA, Fischman MW (1993) Should protracted withdrawel from drugs be included in DSM-IV? Am J Psychiatry 150: 695–704

    PubMed  CAS  Google Scholar 

  • Savage C, Karp EG, Curran SF et al. (1976) Methadone/LAAM maintenance: a comparison study. Compr Psychiatry 17: 415–424

    PubMed  CAS  Google Scholar 

  • Scherbaum N, Gastpar M, Kienbaum P, Deters J (1999) Opiatabhängigkeit: der Ultra-Kurz-Entzug. Dtsch Ärzteblatt 96: 1630–1634

    Google Scholar 

  • Schmidt LG, Gastpar M, Falkei P, Gaebel W (Hrsg) (2006) Evidenzbasierte Suchtmedizin. Behandlungsleitlinien bei substanzbezogene Störungen. Deutscher Ärzteverlag, Köln

    Google Scholar 

  • Schuckit MA (1994) Alcohol and depression: A clinical perspective. Acta Psychiatr Scand Suppl 377: 28–32

    PubMed  CAS  Google Scholar 

  • Schuchardt V, Hacke W (2000) Klinik und Therapie alkoholassoziierter Störungen. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg) Handbuch Alkohol, Alkoholismus, alkoholbedingte Organschäden. Johann Ambrosius Barth, Heidelberg, S 516–537

    Google Scholar 

  • Schötz Ch, Soyka M (1997) Modellpsychosen, Rauschdrogen, Komorbidität von Sucht und Schizophrenie. Kann die Schizophrenieforschung von der Suchtforschung profitieren? In: Soyka M, Möller HJ (Hrsg) Alkoholismus als psychische Störung. Springer, Berlin Heidelberg New York Tokio, S 97–114

    Google Scholar 

  • Sellers EM, Kalant H (1976) Alcohol intoxication and withdrawal. N Engl J Med 294: 757–762

    Article  PubMed  Google Scholar 

  • Sellers EM, Naranjo CA, Harrison M et al. (1983) Diazepam loading: simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 34: 822–826

    PubMed  CAS  Google Scholar 

  • Sharp CW, Beavais F, Spence P (eds) (1992) Inhalant abuse: A volatile research agende. Rockville, Maryland (NIDA Research Monograph 129)

    Google Scholar 

  • Shaw JM, Kolesar GS, Sellers EM et al. (1981) Development of optimal treatment tactics for alcohol withdrawal: I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1: 382–389

    PubMed  CAS  Google Scholar 

  • Shi D, Nokodijevic O, Jacobson KA, Daly JW (1993) Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain. Cell Molecular Neurobiol 13: 247–261

    CAS  Google Scholar 

  • Silagy C, Lancaster T, Stead l et al. (2001) Nicotine replacement therapies in smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 4, Update Software, Oxford

    Google Scholar 

  • Simpson DD, Sells SB (1982) Effectiveness of treatment for drug abuse: An overview of the DARP Research Program. Adv Alcohol Subst Abuse 2: 27–29

    Google Scholar 

  • Simpson DD, Sells SB (eds) (1990) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malaber/FL

    Google Scholar 

  • Soyka M (1995 a) Anti-Craving-Substanzen in der Rückfallprophylaxe der Alkoholabhängigkeit. Sucht 41: 265–276

    Google Scholar 

  • Soyka M (1995 b) Die Alkoholkrankheit — Diagnostik und Therapie. Chapman & Hall, Weinheim

    Google Scholar 

  • Soyka M (1995c) Naltrexon in der Behandlung von Abhängigkeitserkrankungen. Psychopharmakotherapie 3: 110–114

    Google Scholar 

  • Soyka M (1997) Alkoholismus — eine Krankheit und ihre Therapie. Wissenschaftliche Verlagsgesellschaft. Stuttgart

    Google Scholar 

  • Soyka M (1998) Medikamenten-und Drogenabhängigkeit. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Soyka M (1999) Alkoholabhängigkeit — Grundlagen und Therapie. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Soyka M (2006) Alkoholhalluzinose und Eifersuchtswahn. Fortschr Neurol Psychiat 74: 346–357

    PubMed  CAS  Google Scholar 

  • Soyka M, Steinberg R, Vollmer M (1988) Entzugsphänomene bei schrittweisem Benzodiazepinentzug. Nervenarzt 59: 744–748

    PubMed  CAS  Google Scholar 

  • Soyka M, Lutz W, Kauert G, Schwarz A (1989) Epileptic seizures and alcohol withdrawal: significance of additional use (and misuse) of drugs and electroencephalographic findings. J Epilepsy 2: 109–113

    Google Scholar 

  • Soyka M, Krupinski M, Völkl G (1993) Phänomenologie einer ketamininduzierten Psychose. Sucht 5: 327–331

    Google Scholar 

  • Soyka M, Banzer K, Buchberger R et al. (1997) Methadon-Substitution Opioidabhängiger — Katamnestische Ergebnisse und klinische Erfahrungen eines 7jährigen wissenschaftlichen Forschungsprojekts. Nervenheilkunde 68: 347–352

    Google Scholar 

  • Soyka M, Koch W, Tatsch K (2005 a) Thalamic hypofunction in alcohol hallucinosis: FDG PET findings. Psychiatry Res Neuroimaging 30: 259–262

    Google Scholar 

  • Soyka M, Hock B, Kagerer S et al. (2005 b) Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients. J Clin Psychopharmacol 25: 1–4

    Google Scholar 

  • Soyka M, Queri S, Küfner H, Rösner S (2005 c) Wo verstecken sich 1,9 Millionen Medikamentenabhängige? Nervenarzt 76: 72–77

    PubMed  CAS  Google Scholar 

  • Soyka M, Banzer K, Erbas B et al. (2006) Substitutionsbehandlung Drogenabhängiger — rechtliche Grundlagen und neue Ergebnisse der Therapieforschung. Nervenheilkunde 25: 286–294

    Google Scholar 

  • Spanagel R, Hölter SM, Allingham K et al. (1996 a) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305: 39–44

    PubMed  CAS  Google Scholar 

  • Spanagel R, Putzke J, Stefferl A et al. (1996 b) Acamprosate and alcohol. II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305: 45–50

    PubMed  CAS  Google Scholar 

  • Spanagel R, Zieglgänsberger W, Hundt W (1996 c) Acamprosate and alcohol: III. Effects on alcohol discrimination in the rat. Eur J Pharmacol 305: 51–56

    PubMed  CAS  Google Scholar 

  • Spanagel R, Pendyala G, Abarca C et al. (2005) The circadian clock gene Period 2 influences the glutamatergic system and thereby modulates alcohol consumption. Nat Med 11: 35–42

    PubMed  CAS  Google Scholar 

  • Steinglass P (1983) Ein lebensgeschichtliches Modell der Alkoholismusfamilie. Familiendynamik 8: 69–91

    Google Scholar 

  • Stempel J (2006) Rauschgiftlage 2004. In: DHS (Hrsg) Jahrbuch Sucht 06. Neuland, Geesthacht, S 104–113, 141–153

    Google Scholar 

  • Sterns RH, Riggs JE, Schochet SS (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314: 1535–1542

    PubMed  CAS  Google Scholar 

  • Süß HM (1995) Zur Wirksamkeit der Therapie bei Alkoholabhängigen: Ergenisse einer Meta-Analyse. Psychol Rundschau 46: 248–266

    Google Scholar 

  • Sullivan LE, Fiellin DA, O’Connor PG (2005) The prevalence and impact of alcohol problems in major depression: A systematic review. Am J Medicine 118: 330–341

    Google Scholar 

  • Termorshuizen F, Krol A, Prins M, et al. (2005) Long-term Outcome of Chronic Drug Use. Am J Epidemiology 161: 271–279

    Google Scholar 

  • Thomasius R, Jarchow C (1997) »Ecstasy« — Psychotrope Effekte, Komplikationen, Folgewirkungen. Dtsch Ärztebl 7: B309–B312

    Google Scholar 

  • Thomasius R (1999) Psychiatrische, neurologische und internistische Komplikationen und Folgewirkungen. In: Thomasius R (Hrsg) Ecstasy: Wirkungen, Risiken, Interventionen. Ein Leitfaden für Klinik und Praxis, Enke, Stuttgart, S 61–69

    Google Scholar 

  • Thomasius R, Gouzoulis-Mayfrank E et al. (2004) AWMF-Leitlinie: Psychische und Verhaltensstörungen durch Kokain, Amphetamine, Ecstasy und Halluzinogene. Fortschr Neurol Psychiatr 72: 679–695

    PubMed  CAS  Google Scholar 

  • Thomasius R, Goutzoulis-Mayfranck E (2006) Psychische und verhaltensbezogene Störungen durch Kokain, Amphetamine, Ecstasy und Halluzinogene. In: Schmidt LG, Gastpar M, Falkai P, Gaebel W (Hrsg.): Evidenzbasierte Suchtmedizin, Behandlungsleitlinien substanzbezogene Störungen. Deutscher Ärzteverlag, Köln, S 241–270

    Google Scholar 

  • Thome J, Wiesbeck GA, Vince GH (1994) Carbamazepin in der Behandlung des Alkoholentzugssyndroms — Eine Übersicht zum aktuellen Forschungsstand. Fortschr Neurol Psychiatr 62: 125–133

    PubMed  CAS  Google Scholar 

  • Tiihonen J, Ryynänen OO, Kauhanen J et al. (1996) Citalopram in the treatment of alcoholism: A double-blind placebo-controlled study. Pharmacopsychiatry 29: 27–29

    PubMed  CAS  Google Scholar 

  • Tollefson GD, Montague-Clouse J, Tollefson SL (1992) Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12: 19–26

    PubMed  CAS  Google Scholar 

  • Tretter F (1996) Von der Phantasie, die Sucht auszuschlafen. Münch Med Wochenschr 138: 76–77

    Google Scholar 

  • Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152: 332–340

    PubMed  CAS  Google Scholar 

  • US Dept Health and Human Services (1991) National household survey on drug abuse, population estimates 1991. National Institute on Drug Abuse, Rockville/MD

    Google Scholar 

  • Victor M (1992) The effects of alcohol on the nervous system. In: Mendelson JH, Mello NK (eds) Medical diagnosis and treatment of alcoholism. Mc Graw-Hill, New York, pp 201–262

    Google Scholar 

  • Victor M, Laureno R (1978) The neurologic complications of alcohol abuse: Epidemiologic aspects. In: Schoenberg BS (ed) Advances in neurology, vol 19. Neurological epidemiology: Principles and clinical applications. Raven, New York, pp 603–617

    Google Scholar 

  • Volpe JJ (1992) Effects of cocaine use on the fetus. New Engl J Med 327: 399–407

    Article  PubMed  CAS  Google Scholar 

  • Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876–880

    PubMed  CAS  Google Scholar 

  • Warner LA, Kessler RC, Hughes M et al. (1995) Prevalence and correlates of drug use and dependence in the united states. Arch Gen Psychiatry 52: 219–229

    PubMed  CAS  Google Scholar 

  • Whitfield CL, Thompson G, Lang A et al. (1978) Detoxification of 1024 alcoholic patients without psychoactive drugs. JAMA 293: 1409–1410

    Google Scholar 

  • Whitworth AB, Fischer F, Lesch OM et al. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347: 1438–1442

    PubMed  CAS  Google Scholar 

  • Wienberg G (1992) Die vergessende Mehrheit. Psychiatrie-Verlag, Bonn

    Google Scholar 

  • Woolverton WL, Johnson KM (1992) Neurobiology of cocaine Abuse. TIPS 13: 193–200

    PubMed  CAS  Google Scholar 

  • Zumdick S, Schneider U, Leweke M et al. (2006) Studienlage zur Behandlung der Cannabisabhängigkeit. Fortschr Neurol Psychiat 74: 211–225

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Privatklinik Meiringen, Postfach 612, 3860, Meiringen, Schweiz

    Prof. Dr. M. Soyka

Authors
  1. Prof. Dr. M. Soyka
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum der Ludwig-Maximilians-Universität München, Nußbaumstr. 7, 80336, München

    Hans-Jürgen Möller

  2. Inn-Salzach-Klinikum Wasserburg a. Inn · Rosenheim · Freilassing Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie Akademisches Lehrkrankenhaus, Ludwig-Maximilians-Universität München, Gabersee 7, 83512, Wasserburg am Inn

    Gerd Laux

  3. Klinik für Psychiatrie, Medizinische Universität Graz, Auenbruggerplatz 31, 8036, Graz, Österreich

    Hans-Peter Kapfhammer

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Soyka, M. (2008). Störungen durch Alkohol. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33129-2_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33129-2_49

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24583-4

  • Online ISBN: 978-3-540-33129-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation